Dr Denis Donohue of the FDA asked pharmaceutical companies to stop using blood collected from donors likely to have high levels of antibodies to Hepatitis.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Dennis Donohue